The estrous cycle modulates early-life adversity effects on mouse avoidance behavior through progesterone signaling.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
07 12 2022
Historique:
received: 06 03 2022
accepted: 17 11 2022
entrez: 8 12 2022
pubmed: 9 12 2022
medline: 15 12 2022
Statut: epublish

Résumé

Early-life adversity (ELA) increases the likelihood of neuropsychiatric diagnoses, which are more prevalent in women than men. Since changes in reproductive hormone levels can also increase the probability of anxiety disorders in women, we examined the effects of ELA on adult female mice across the estrous cycle. We found that during diestrus, when progesterone levels are relatively high, ELA mice exhibit increased avoidance behavior and increased theta oscillation power in the ventral hippocampus (vHIP). We also found that diestrus ELA mice had higher levels of progesterone and lower levels of allopregnanolone, a neurosteroid metabolite of progesterone, in the vHIP compared with control-reared mice. Progesterone receptor antagonism normalized avoidance behavior in ELA mice, while treatment with a negative allosteric modulator of allopregnanolone promoted avoidance behavior in control mice. These results suggest that altered vHIP progesterone and allopregnanolone signaling during diestrus increases avoidance behavior in ELA mice.

Identifiants

pubmed: 36476469
doi: 10.1038/s41467-022-35068-w
pii: 10.1038/s41467-022-35068-w
pmc: PMC9729614
doi:

Substances chimiques

Progesterone 4G7DS2Q64Y
Pregnanolone BXO86P3XXW

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

7537

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH117459
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022. The Author(s).

Références

J Affect Disord. 1992 Aug;25(4):251-9
pubmed: 1430661
Menopause. 2018 Nov;25(11):1275-1285
pubmed: 30358723
Am J Psychiatry. 2016 Nov 1;173(11):1083-1093
pubmed: 27609244
Front Behav Neurosci. 2021 Jul 20;15:710725
pubmed: 34354574
Curr Psychiatry Rep. 2015 Nov;17(11):87
pubmed: 26377947
Nat Neurosci. 2007 Nov;10(11):1401-3
pubmed: 17906620
Dev Psychopathol. 2012 Nov;24(4):1401-16
pubmed: 23062306
J Pharmacol Exp Ther. 1995 Dec;275(3):1412-7
pubmed: 8531110
Horm Behav. 2020 Aug;124:104763
pubmed: 32407728
Psychopharmacology (Berl). 2014 Sep;231(17):3569-80
pubmed: 24781515
J Neurosci. 2016 Nov 9;36(45):11459-11468
pubmed: 27911749
Brain Res. 1999 Dec 11;850(1-2):217-24
pubmed: 10629767
Behav Brain Res. 2011 Sep 12;222(1):223-9
pubmed: 21463656
Psychophysiology. 2020 Oct;57(10):e13632
pubmed: 33400260
J Neuroendocrinol. 2022 Feb;34(2):e13013
pubmed: 34337790
Neuron. 2015 Jun 3;86(5):1277-89
pubmed: 26050044
Front Behav Neurosci. 2013 Oct 14;7:127
pubmed: 24137113
Expert Rev Neurother. 2007 Nov;7(11 Suppl):S93-113
pubmed: 18039072
Trauma Violence Abuse. 2016 Dec;17(5):427-453
pubmed: 25985988
Front Mol Neurosci. 2019 Feb 26;12:27
pubmed: 30863281
J Endocrinol. 1987 Jan;112(1):15-21
pubmed: 3819629
Trends Neurosci. 2020 Apr;43(4):200-212
pubmed: 32209452
PLoS One. 2018 Nov 26;13(11):e0207804
pubmed: 30475877
J Neurobiol. 2005 Jul;64(1):34-46
pubmed: 15884004
J Neurosci. 2020 Jun 24;40(26):5008-5018
pubmed: 32457072
BMC Neurosci. 2010 Sep 29;11:123
pubmed: 20920223
Learn Mem. 2004 Mar-Apr;11(2):137-44
pubmed: 15054128
Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14602-7
pubmed: 16984997
PLoS One. 2012;7(4):e35538
pubmed: 22514749
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
J Affect Disord. 2017 Aug 1;217:218-224
pubmed: 28431382
Neural Plast. 2018 Feb 4;2018:5735789
pubmed: 29531525
Horm Behav. 2016 Jul;83:60-67
pubmed: 27178577
Psychiatry Clin Neurosci. 2004 Dec;58(6):593-9
pubmed: 15601382
Psychiatry Res. 2014 Jan 30;215(1):192-201
pubmed: 24268580
Front Syst Neurosci. 2022 Jun 23;16:860847
pubmed: 35813268
Clin Psychol Rev. 2009 Feb;29(1):1-23
pubmed: 19019513
Neuron. 2012 Aug 9;75(3):410-7
pubmed: 22884325
Nat Commun. 2020 May 8;11(1):2261
pubmed: 32385304
Mol Psychiatry. 2022 Aug;27(8):3192-3203
pubmed: 35760878
Psychoneuroendocrinology. 2020 Feb;112:104512
pubmed: 31780185
Neuropsychiatr Dis Treat. 2020 Jan 06;16:1-10
pubmed: 32021194
Menopause. 2020 Jul;27(7):746-755
pubmed: 32187134
Pharmacol Biochem Behav. 1998 Jan;59(1):221-32
pubmed: 9443559
Psychol Med. 2016 Mar;46(4):717-30
pubmed: 26708271
Ann Gen Psychiatry. 2014 Sep 16;13:26
pubmed: 25648979
Int J Mol Sci. 2022 Jun 30;23(13):
pubmed: 35806264
Neuropharmacology. 2012 Jan;62(1):155-60
pubmed: 21723303
J Vis Exp. 2012 Sep 15;(67):e4389
pubmed: 23007862
J Neurosci. 2010 May 5;30(18):6387-97
pubmed: 20445065
J Affect Disord. 2000 Dec;61(3):161-76
pubmed: 11163419
J Pharmacol Exp Ther. 1993 Jun;265(3):1374-9
pubmed: 8389864
Biol Psychiatry. 2019 Sep 15;86(6):421-432
pubmed: 31221426
Steroids. 2003 Nov;68(10-13):1019-32
pubmed: 14667995
Women Health. 2018 Mar;58(3):305-319
pubmed: 28278011
Behav Brain Res. 2001 Feb 15;119(1):41-7
pubmed: 11164524
Neurosci Behav Physiol. 2007 Oct;37(8):843-8
pubmed: 17922250
Neurosci Behav Physiol. 2003 May;33(4):415-20
pubmed: 12774846
Neurobiol Stress. 2015 Jan;1:60-65
pubmed: 25729759
Neuropsychopharmacology. 2019 Mar;44(4):711-720
pubmed: 30188513
J Affect Disord. 2003 Mar;74(1):85-96
pubmed: 12646301
Brain Res. 1997 Aug 22;766(1-2):276-80
pubmed: 9359616
Front Synaptic Neurosci. 2021 May 10;13:673210
pubmed: 34040511
Neuron. 2010 Jan 28;65(2):257-69
pubmed: 20152131
J Psychiatr Res. 2017 Jan;84:119-127
pubmed: 27728852
J Pharmacol Exp Ther. 2013 Jul;346(1):146-60
pubmed: 23667248
Nat Commun. 2021 May 3;12(1):2496
pubmed: 33941789
Behav Ther. 2021 May;52(3):734-744
pubmed: 33990246
Curr Psychiatry Rep. 2008 Aug;10(4):331-5
pubmed: 18627672
Fertil Res Pract. 2020 Mar 14;6:5
pubmed: 32190339
Aging (Albany NY). 2017 Jun 28;9(6):1607-1622
pubmed: 28657900
Behav Neurosci. 2001 Feb;115(1):175-87
pubmed: 11256441
J Vis Exp. 2012 Jun 07;(64):e4013
pubmed: 22710371
Behav Med. 2008 Winter;33(4):125-35
pubmed: 18316270
J Psychiatr Res. 2018 Jul;102:207-215
pubmed: 29689518
Stress. 1999 Dec;3(2):163-71
pubmed: 10938577
Child Abuse Negl. 2020 Oct;108:104637
pubmed: 32768748
J Affect Disord. 2016 Jan 15;190:47-55
pubmed: 26480211
Psychoneuroendocrinology. 2018 Jul;93:133-141
pubmed: 29727810
Cogn Affect Behav Neurosci. 2001 Sep;1(3):287-96
pubmed: 12467128
Exp Brain Res. 1983;52(1):41-9
pubmed: 6628596
Brain Res. 1975 Sep 23;95(2-3):323-42
pubmed: 168940
J Psychiatr Res. 2009 Jun;43(9):877-83
pubmed: 19162277
Methods Find Exp Clin Pharmacol. 1997 Dec;19(10):665-81
pubmed: 9542718
eNeuro. 2020 Jul 31;7(4):
pubmed: 32719104
Horm Metab Res. 2014 Mar;46(3):211-8
pubmed: 24446162
Depress Anxiety. 2021 Mar;38(3):307-317
pubmed: 33465284
J Pharmacol Exp Ther. 2003 May;305(2):541-8
pubmed: 12606703
Physiol Behav. 2005 Mar 31;84(4):585-94
pubmed: 15811394
Eur J Neurosci. 2020 Jul;52(1):2664-2680
pubmed: 31660665
Neuron. 2019 Nov 6;104(3):601-610.e4
pubmed: 31521441
Pharmacol Ther. 2007 Oct;116(1):58-76
pubmed: 17512983
Neuroendocrinology. 2004;80(5):308-23
pubmed: 15677881
Am Psychol. 2021 Feb-Mar;76(2):350-363
pubmed: 33734800
Front Behav Neurosci. 2021 Mar 09;15:595049
pubmed: 33767614
J Endocrinol Invest. 1995 Dec;18(11):853-6
pubmed: 8778157
Physiol Behav. 1987;39(4):513-9
pubmed: 3575499
Dev Neurosci. 2020;42(2-4):135-144
pubmed: 33341802
Hippocampus. 2012 Sep;22(9):1848-59
pubmed: 22467298
Psychopharmacology (Berl). 2006 Jun;186(3):343-50
pubmed: 16491430
Lancet. 2017 Dec 17;388(10063):3048-3059
pubmed: 27349358
J Affect Disord. 2018 Feb;227:869-877
pubmed: 29254068
Can J Psychiatry. 2006 Feb;51(2):100-13
pubmed: 16989109
J Psychiatr Res. 2011 Aug;45(8):1027-35
pubmed: 21439576
J Clin Psychiatry. 2006 Aug;67(8):1285-98
pubmed: 16965210
JAMA Psychiatry. 2019 Aug 1;76(8):843-853
pubmed: 31241756
Psychopharmacology (Berl). 2020 May;237(5):1281-1290
pubmed: 31965254
Horm Behav. 2018 Jun;102:34-40
pubmed: 29673619
Nat Commun. 2016 Jun 16;7:11937
pubmed: 27306314
Neuroendocrinology. 2004;80(6):387-93
pubmed: 15741744
Neurobiol Stress. 2019 Mar 09;10:100155
pubmed: 30949564
Biol Psychiatry. 2019 Jun 15;85(12):1011-1020
pubmed: 31027646

Auteurs

Blake J Laham (BJ)

Princeton Neuroscience Institute, Princeton, NJ, 08450, USA.

Sahana S Murthy (SS)

Princeton Neuroscience Institute, Princeton, NJ, 08450, USA.

Monica Hanani (M)

Princeton Neuroscience Institute, Princeton, NJ, 08450, USA.

Mona Clappier (M)

Princeton Neuroscience Institute, Princeton, NJ, 08450, USA.

Sydney Boyer (S)

Princeton Neuroscience Institute, Princeton, NJ, 08450, USA.

Betsy Vasquez (B)

Princeton Neuroscience Institute, Princeton, NJ, 08450, USA.

Elizabeth Gould (E)

Princeton Neuroscience Institute, Princeton, NJ, 08450, USA. goulde@princeton.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH